Director-General of Infectious Diseases, AIDS and Clinical Immunology Research Center, Tengiz Tsertsvadze, said that treatment of COVID-19 using monoclonal antibodies will produce the best possible results.
In Tsertsvadze's words, monoclonal antibodies which prevent the virus from progressing will be used in mild patients for now.
''New monoclonal antibodies are being tested now. Receiving those which are used in patients with severe symptoms will be a tremendous step forward,'' Tengiz Tsertsvadze stated.
Monoclonal antibodies are set to arrive in Georgia in the near future. Deputy Health Minister Tamar Gabunia said that two different antibodies will be donated to Georgia.
The US Food and Drug Administration has recently approved monoclonal antibody sotrovimab for emergency use in 12-year-olds and older patients.
